MissionIR Archives - Page 2 of 5

Thursday Nov 07, 2024 - 12:57 pm

InvestorNewsBreaks – Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Moving to Benefit from Increased Demand for PGMs

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is poised to benefit from the automotive industry’s shift toward hybrid and electric vehicles (“EVs”). “A surge in sales of hybrid cars as electric vehicle take-up slows is set to provide an unexpected boost to demand for platinum group metals (‘PGMs’) in the coming years, similar to the extended lifespan now predicted for coal,” reads a…

Tuesday Oct 29, 2024 - 12:51 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Moving Closer to Providing Much-Needed Treatments to Patients

Annovis Bio (NYSE: ANVS) is a late-stage clinical drug platform company pioneering novel therapies for neurodegenerative diseases. Recent clinical trials of the company’s lead compound yielded encouraging results, with buntanetap shown to improve cognition in both Alzheimer’s and Parkinson’s patients. The company also introduced a new crystalline form of buntanetap with improved properties, “offering significant advantages over the less structured, old semi-crystalline form,” according to…

Thursday Oct 24, 2024 - 12:53 pm

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Set to Discuss Lead Candidate Biomarker with FDA Leadership

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (“ALS”) and multiple sclerosis (“MS”), recently announced an upcoming meeting with U.S. Food and Drug Administration (“FDA”) leadership. The focus is to discuss Clene’s CNM-Au8® biomarker and related clinical and survival data…

Monday Oct 21, 2024 - 1:23 pm

InvestorNewsBreaks – Platinum Group Metals Ltd.’s (NYSE American: PLG) (TSX: PTM) Lion Battery Accelerating Development of Next-Gen Technology

Platinum Group Metals (NYSE American: PLG) (TSX: PTM), through its subsidiary Lion Battery, is working to strengthen its foothold in the lithium-sulfur space. With new technologies being researched and developed to rival lithium-ion batteries in terms of efficiency, cost and sustainability, lithium-sulfur batteries could offer advantages. “Lion Battery was jointly formed in 2019 by Platinum Group and Anglo American Platinum to accelerate the development of…

Friday Sep 20, 2024 - 3:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Evaluating ‘More Effective, Tolerable’ Oral Delivery of GLP-1 Drugs

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, looks to offer a better alternative to diabetes management and treatment through its patented DehydraTECH(TM) technology. “Lexaria has recently made strides with glucagon-like peptide-1 (‘GLP-1’) studies. It has reported positive interim results from an animal study on diabetes. This milestone best showcases the potential of its patented technology in not only addressing diabetes…

Friday Sep 20, 2024 - 2:20 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Stands Distinct from Industry Players with Buntanetap

Annovis Bio (NYSE: ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, secured U.S. patent No. 12,042,482 covering methods for treating traumatic brain injury (“TBI”) and nerve injury with buntanetap, the company’s lead drug candidate. “Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins such as amyloid beta, tau, alpha-synuclein, and TDP43; by inhibiting their translation, the drug…

Friday Sep 13, 2024 - 3:27 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Market Potential with Unique Delivery Platform, GLP-1 Program

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). “Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D expenditures and experienced other savings,” reads a recent article. “Most…

Friday Aug 30, 2024 - 2:45 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) BayMedica Poised as Rare Cannabinoids Drive Market Growth

InMed Pharmaceuticals’ (NASDAQ: INM) subsidiary BayMedica is positioned amid a growing interest in edibles infused with non-intoxicating minor cannabinoids. These lesser-known cannabinoids offer unique properties and potential health benefits, driving significant market growth. The company published a report on the expansion of the minor cannabinoid market in 2023. “The report, based on data from Headset, the largest industry dataset, explores the growth, competition and consumer…

Friday Aug 30, 2024 - 2:15 pm

InvestorNewsBreaks – Annovis Bio Inc. (NYSE: ANVS) Expands Team in Continued Focus to Make Meaningful Impact on Lives of AD, PD Patients

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), recently welcomed four seasoned professionals to its executive team. “Annovis Bio is excited about the new additions and confident that these highly experienced professionals will significantly contribute to the company’s mission of developing transformative therapies for neurodegenerative diseases.…

Thursday Aug 29, 2024 - 11:48 am

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Facilitating Global Transition Toward Solar

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation. “With its unique market positioning, Correlate is facilitating the global solar energy transition, offering important additional benefits associated with its adoption, encouraging profitability and overall sustainability while reducing carbon footprint. So far, Correlate has developed,…

Friday Aug 23, 2024 - 3:00 pm

InvestorNewsBreaks – Why Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) Is ‘One to Watch’

Platinum Group Metals Ltd. (NYSE American: PLG) (TSX: PTM) is the operator of the Waterberg Project, a bulk underground platinum group metals (“PGM”) deposit discovered by Platinum Group in 2011 and located on the Northern Limb of the Bushveld Complex in South Africa. “The Waterberg Project is planned as a fully mechanized platinum, palladium, rhodium and gold mine, including by-product copper and nickel production, and…

Thursday Aug 22, 2024 - 2:30 pm

InvestorNewsBreaks – PaxMedica Inc. (PXMD) Committed to Global Health, Potential Positive Impact of PAX-101

PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorder treatments, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration for suramin to treat Human African Trypanosomiasis (“HAT”). “In April 2024, PaxMedica underscored its commitment to global health by responding to an urgent request from Malawi for an emergency release of suramin, demonstrating its dedication to advancing healthcare…

Thursday Aug 22, 2024 - 1:37 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Positioned for Opportunity Amid Unstoppable Trend

Correlate (OTCQB: CIPI) is positioned as a combination of unprecedented levels of government incentives and growing private sector investment funding are pushing a noteworthy shift in energy trends. The momentum shows decentralized electrical energy generation gaining an increasing following according to an MSE Investments report praising the visionary qualities of Correlate Energy. “The distributed energy solutions company recently announced its coming role in co-developing the…

Thursday Aug 22, 2024 - 1:04 pm

InvestorNewsBreaks – SenesTech Inc.’s (NASDAQ: SNES) Evolve(TM) Offers Proactive Approach to Growing Rat Problem

SenesTech’s (NASDAQ: SNES) flagship product, Evolve(TM), has repeatedly demonstrated an effective rat control alternative to current market offerings. “The active ingredient in the product has been scientifically proven to reduce rodent fertility, ultimately offering a more proactive approach to addressing the growing rat problem, as opposed to a more reactive approach, as is the case with poisons and traps. The obvious argument is that it’s…

Friday Aug 16, 2024 - 3:03 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-089 Showing Great Promise in Treating AMD

InMed Pharmaceuticals (NASDAQ: INM), a clinical stage company developing a pipeline of pharmaceutical drug candidates to treat several diseases with a high unmet medical need, is at the forefront of developing innovative treatment for age-related macular degeneration (“AMD”), with its flagship product INM-089 showing great promise. “AMD is a prevalent eye condition that primarily affects older adults, leading to vision loss in the central part…

Friday Aug 16, 2024 - 2:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Opportunity from First-Ever Work with Tirzepatide Molecule

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, recently hired a Contract Research Organization (“CRO”) for its third human pilot study. “This marks a milestone for the company, notably since it announced its focus solely on glucagon-like peptide 1 (‘GLP-1’) studies for the 2024 calendar year… This randomized, crossover investigation will evaluate a dual-action GLP-1 + glucose-dependent insulintropic peptide (‘GIP’), specifically…

Friday Aug 16, 2024 - 2:09 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Addressing ‘Significant Problem’ with Resilient Energy Solutions

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is driving scalability in the microgrid energy distribution market. This follows a new partnership between its subsidiary Distributed Energy Capital (“DEC”) and clean energy development innovator Compass Energy that will establish the United States’ first microgrid utility. “The landmark initiative by Distributed Energy Capital and Compass Energy Platform…

Wednesday Aug 14, 2024 - 2:00 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) CEO Showcases Strategic Approach to Industry

McEwen Mining (NYSE: MUX) (TSX: MUX) is an asset-rich diversified gold and silver producer in the Americas. McEwen CEO Rob McEwen recently spoke at the NYC SME’s 9th Annual Current Trends in Mining Finance Conference, where he emphasized the crucial importance of the mining industry to modern civilization and outlined a strategic approach to improving its public perception. “The central theme of McEwen’s speech was…

Friday Jul 12, 2024 - 12:04 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Expanding Solutions to Significant Untapped Market

Correlate (OTCQB: CIPI), a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America, is strategically working with partners to help clients facilitate green energy transition and improvements. “Correlate Energy is expanding its renewable energy adoption services into a significant untapped market, thanks to a new corporate partnership, a new federal funding program benefitting low-income communities, and a non-profit insurance company designed…

Thursday Jul 11, 2024 - 2:30 pm

InvestorNewsBreaks – McEwen Mining Inc. (NYSE: MUX) (TSX: MUX) Positioned as Standout Opportunity for Investors

McEwen Mining’s (NYSE: MUX) (TSX: MUX) share price has shown a remarkable gain of 62.1% over the last 12 weeks, indicating strong momentum and robust performance in the market. “This trend of sustained positive momentum over time is a key indicator of the stock’s potential for continued growth, making it an attractive option for those looking to capitalize on price strength… McEwan Mining’s financial health…

Thursday Jul 11, 2024 - 2:00 pm

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Significant Improvements from INM-089 in AMD, Validates INM-901 as Potential AD Treatment

InMed (NASDAQ: INM) is a clinical stage pharmaceutical company focused on developing a pipeline of proprietary small molecule drug candidates targeting the CB1/CB2 receptors. The company recently released several critical updates regarding its INM-089 therapy treating dry Age-related Macular Degeneration (“AMD”) and its INM-901 small molecule drug candidate targeting Alzheimer’s disease (“AD”). “Recent preclinical data for INM-089 demonstrated significant functional and pathological improvements in an…

Wednesday Jul 10, 2024 - 12:30 pm

InvestorNewsBreaks – Astrotech Corporation (NASDAQ: ASTC) Sets New Standard for Accuracy, Reliability in Narcotics Detection

Astrotech (NASDAQ: ASTC), through its subsidiary 1st Detect, is revolutionizing narcotics and explosives trace detection. “With recent approval as a U.S. General Services Administration (‘GSA’) authorized vendor, 1st Detect is poised to expand its impact across government agencies. TRACER 1000 is a cutting-edge detector utilizing ruggedized mass spectrometry technology for superior detection at critical security points. 1st Detect’s commitment to excellence is underscored by its…

Monday Jul 01, 2024 - 12:37 pm

InvestorNewsBreaks – PaxMedica Inc. (PXMD) Intensifying Efforts to Achieve Significant Program Milestones

PaxMedica (OTC: PXMD), a biopharmaceutical company specializing in neurological disorders, is preparing to submit a New Drug Application (“NDA”) to the U.S. Food and Drug Administration (“FDA”) for using suramin to treat Human African Trypanosomiasis (“HAT”), a well-established treatment in East Africa for nearly a century. A recent article discussed PaxMedica gearing up for a significant Type C meeting it had with the FDA, which…

Friday Jun 28, 2024 - 2:30 pm

InvestorNewsBreaks – Correlate Energy Corp. (CIPI) Helping Companies ‘Beat the Grid for Costs’

Correlate (OTCQB: CIPI) is a tech-enabled development, finance and fulfillment platform for distributed energy solutions across North America. “Correlate Energy is a unique source for helping make renewable energy accessible to companies seeking to transition from more carbon-intensive fuels as part of a worldwide effort to forestall the harms of pollution-driven changes to the environment. The company’s focus on solar energy infrastructure, for example, is…

Thursday Jun 27, 2024 - 3:30 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Eyeing Favorable Strategic Partnering with Leading GLP-1 Players

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, is doubling down on glucagon-like peptide 1 (“GLP-1”) studies for the 2024 calendar year. “The company is optimistic that the studies will yield positive results, not just in the potential treatment of diabetes but also in weight management, which has been directly linked to diabetes… The company recently received independent third-party ethics review…

Monday Mar 25, 2024 - 10:45 am

InvestorNewsBreaks — The Register Interviews D-Wave Quantum Inc. (NYSE: QBTS), Highlights Quantum Computing’s Potential Impact on AI

The Register, a British technology news website with millions of unique visitors per month, recently published an article about OpenAI’s recent interest in quantum. To gain insight, The Register interviewed Murray Thom, D-Wave's VP of Quantum Technology Evangelism, and Trevor Lanting, D-Wave's Chief Development Officer. Lanting explained, "As you're training [an AI] model, the number of parameters that go into the model really drives the…

Thursday Mar 21, 2024 - 12:15 pm

InvestorNewsBreaks – Freight Technologies Inc. (NASDAQ: FRGT) Continuing to Redefine Logistics Landscape with Innovative Solutions

Freight Technologies (NASDAQ: FRGT) (“Fr8Tech”) is a technology company whose custom-developed, industry-leading Fr8App freight-matching platform offers a real-time portal for B2B cross-border and domestic shipping within the USMCA region. The company has been Riisa’s trusted logistics supplier for over two years, facilitating cross-border exportations and enabling Riisa to move its products with ease and efficiency. In Fr8App’s continued focus on redefining the logistics landscape, it…

Thursday Mar 21, 2024 - 11:58 am

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) CEO to Present at the Upcoming 14th Annual LD Micro Invitational

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced that it will be participating at the 14th Annual LD Micro Invitational at the Sofitel New York on Apr. 8-9, 2024. Lexaria CEO Chris Bunka will be presenting at the event, with his presentation scheduled to begin at 10:30 a.m. ET on Tuesday, Apr. 9. Bunka will discuss the company’s recent…

Thursday Mar 21, 2024 - 11:33 am

InvestorNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR), CEO Recognized at FiNext Conference with Excellence in Finance Awards

FingerMotion (NASDAQ: FNGR), a mobile services and data company, and CEO Martin J. Shen, received recognition at the recent FiNext Conference. At the conference, which was held in Dubai on Feb. 28–29, 2024, FingerMotion and Shen both received awards. Shen was awarded the Excellence in Finance — Leaders Award, and the company was awarded the Excellence in Finance — Companies Award. The Excellence in Finance…

Thursday Mar 21, 2024 - 9:54 am

InvestorNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Receives Notification from NASDAQ of 180-Day Extension

InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing, development and commercialization of rare cannabinoids and proprietary cannabinoid analogs, has been granted an additional 180 days to comply with NASDAQ’s minimum bid price requirement for the continued listing on the NASDAQ Capital Market. InMed received a letter from the exchange notifying it of the extended deadline, which will now be Sept. 16, 2024. According to…

Thursday Mar 21, 2024 - 9:18 am

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Releases Financial Results, Corporate Highlights for Q4, FY 2023

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has announced its financial numbers and operational highlights for the fourth quarter and full year ended Dec. 31, 2023. According to the report, key achievements during the period included enrolling the first patients for a pivotal trial studying AIMIGo(TM) System for synthesizing a 12-lead ECG as well…

Wednesday Mar 20, 2024 - 12:30 pm

InvestorNewsBreaks – Golden Matrix Group Inc. (NASDAQ: GMGI) Stockholders Vote to Approve Proposed MeridianBet Group Acquisition

Golden Matrix (NASDAQ: GMGI), a developer, licensor and global operator of online gaming and eCommerce platforms, systems and gaming content, is moving forward on the acquisition of MeridianBet Group. According to the announcement, GMGI stockholders approved the terms of the merger, which included the issuance of shares of common stock. The transaction was initially announced in June 2023. The announcement reported that stockholders representing 32,406,412…

Wednesday Mar 20, 2024 - 9:45 am

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Releases Info on $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, has entered into definitive agreements. The agreements are for the sale and issuance of 1,542,112 shares of common stock (or prefunded warrants in lieu thereof) of the company and warrants to purchase up to 1,542,112 shares of common stock; the stocks and warrants are offered at…

Wednesday Mar 20, 2024 - 9:28 am

InvestorNewsBreaks — Longeveron Inc. (NASDAQ: LGVN) Board Approves 1-for-10 Reverse Stock Split

Longeveron (NASDAQ: LGVN), a clinical-stage biotechnology company developing regenerative medicines for unmet medical needs, has announced a 1-for-10 reverse split of the company’s Class A common stock. The move was approved by the company’s board of directors during a special stockholder meeting. According to the announcement, the reverse split will become effective at 11:59 p.m. ET on March 26, 2024. Following that, the company’s Class…

Tuesday Mar 19, 2024 - 12:00 pm

InvestorNewsBreaks – Genprex Inc. (NASDAQ: GNPX) Announces $6.5M Registered Direct Offering

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. The company today announced its entry into definitive agreements for the sale and issuance of 1,542,112 shares of its common stock (or prefunded warrants in lieu thereof) and warrants to purchase up to 1,542,112 shares of common stock at a combined offering price of $4.215…

Tuesday Mar 19, 2024 - 11:31 am

InvestorNewsBreaks – Clene Inc.’s (NASDAQ: CLNN) Work in Nanotechnology Highlighted in ‘First in Human’ Podcast

Clene (NASDAQ: CLNN), a late clinical-stage biopharmaceutical company, was featured in a recent episode of First in Human, a biotech-focused podcast featuring interviews with industry leaders and investors to learn about their journeys to in-human clinical trials. Hosted by Vial EVP Rich McCormick, the podcast is available for on-demand listening on First in Human by Vial. Rob Etherington, president, director and CEO of Clene joined…

Monday Mar 18, 2024 - 10:05 am

InvestorNewsBreaks — D-Wave Quantum Inc. (NYSE: QBTS) Schedules Q4, FY 2023 Earnings Call

D-Wave Quantum (NYSE: QBTS) (“D-Wave”), a leader in quantum computing systems, software, and services and the world’s first commercial supplier of quantum computers, plans to release its financial results for the fourth quarter and fiscal year 2023 for the period ended Dec. 31, 2023 before market open on March 28, 2024. In addition, the company has scheduled a conference call that same day to discuss the…

Friday Mar 15, 2024 - 10:34 am

InvestorNewsBreaks – Clene Inc. (NASDAQ: CLNN) Announces Publication of Peer-Reviewed Research for Investigational Drug CNM-Au8(R)

Clene (NASDAQ: CLNN) (along with its subsidiaries, “Clene”) and its wholly owned subsidiary Clene Nanomedicine Inc., a clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, today announced the publication of peer-reviewed research, titled “Protein Corona Composition of Gold Nanocrystals.” The publication appeared in the journal ACS Pharmacology & Translational Science and fully characterized the proteins from human…

Thursday Mar 14, 2024 - 12:47 pm

InvestorNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Names Experienced Corporate Finance Exec as New CFO

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug-delivery platforms, has appointed a new chief financial officer. The company announced that, effective immediately, Nelson Cabatuan, CPA, will serve in the position, which also entails being a member of Lexaria’s executive leadership team. Cabatuan brings more than 15 years of corporate finance and operations experience in the life sciences industry. Most recently, he served as…

Thursday Mar 14, 2024 - 12:00 pm

InvestorNewsBreaks — HeartBeam Inc. (NASDAQ: BEAT) Enrolls First Patients in Key Study Assessing Proprietary AIMIGo(TM) System

HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care through the power of personalized insights, has begun enrolling the first patients in its VALID-ECG pivotal study. According to the announcement, the first patients were enrolled at Atlanta Heart Specialists, a top cardiology physician practice in Atlanta, Georgia. HeartBeam anticipates the VALID-ECG study will form the basis of its planned FDA 510(k) submission.…

InvestorNewsBreaks

NewsBreak Category: MissionIR

Get Started with InvestorWire

Press Distribution

Explore Press Distribution Solutions

Discover Add-on Solutions